Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genetec's EBIT per Share for the
six
months ended in Mar. 2026 was 円57.83.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円73.24.
During the past 12 months, the average EBIT per Share Growth Rate of Genetec was 17.90% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 96.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 38.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Genetec's EBIT per Share or its related term are showing as below:
TSE:4492'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -36.2 Med: 33.65 Max: 96.9
Current: 96.9
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Genetec was 96.90% per year. The lowest was -36.20% per year. And the median was 33.65% per year.
TSE:4492's 3-Year EBIT Growth Rate is ranked better than 96.89% of 2120
companies
in the Software industry
Industry Median: 12
vs TSE:4492: 96.90
Genetec's EBIT for the
six
months ended in Mar. 2026 was 円679 Mil.
Genetec (TSE:4492) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Genetec EBIT per Share Related Terms
Genetec EBIT per Share Historical Data
* Premium members only.
The historical data trend for Genetec's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円73.24
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetec (TSE:4492) has a EBIT per Share of 円73.24 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Genetec and its competitors. According to the industry distribution chart, Genetec ranks #66 out of 2120 companies in the Software industry, placing it in the top 3.1%.
Is Genetec's EBIT per Share too high?
Genetec's current EBIT per Share is 円73.24. Based on the distribution chart, Genetec ranks #66 out of 2120 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Genetec has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genetec's EBIT per Share compare to UBER and SHOP?
According to the Software industry distribution chart, Genetec ranks #66 out of 2120 companies for EBIT per Share. This places Genetec in the top 3% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Software company?
The median EBIT per Share among Software companies is 12.00, based on 2,120 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Genetec and its competitors. For the Software industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetec's current EBIT per Share is 円73.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetec stock overvalued right now?
Based on GuruFocus' analysis, Genetec (TSE:4492) is currently considered Significantly Undervalued. The stock's GF Value™ is 円759.20, compared to a current price of 円412.00 — trading 45.7% below its estimated fair value. The current EBIT per Share is 円73.24. Genetec's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Genetec (TSE:4492), the current EBIT per Share is 円73.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genetec (TSE:4492) Overvalued in 2026?
Based on GuruFocus' analysis, Genetec stock appears to be undervalued.
The current stock price of 円412.00 is trading 45.7% below its estimated GF Value™ of 円759.20.
GuruFocus considers Genetec to be Significantly Undervalued.
Key valuation signals for TSE:4492:
EBIT per Share: 円73.24
GF Value™: 円759.20 vs. price of 円412.00 (45.7% below fair value)
No single metric tells the full story. See the TSE:4492 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genetec Corp is engaged in the provision of system development, engineering, and IOT/cloud solutions. Its services include software development, hardware development, engineering solutions, Mastercam, Robomaster, flexisim, IoT/M2M business, surve-I, Coco Dayo, and web integration.
77GF Score
Get the complete analysis for TSE:4492
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4492 has been successfully added to your 
